Ryaltris, which was developed by Glenmark, is a novel, fixed-dose combination nasal spray of an anti-histamine (olopatadine hydrochloride) and a steroid (mometasone furoate). Each unit of the ...

A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) ...

The first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark ...